News from Epizyme A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Apr 22, 2014, 08:00 ET Epizyme Achieves Lead Candidate Milestone for Third Target in GSK Collaboration, Receives $4 Million in Milestone and License Payments

Epizyme, Inc. (NASDAQ: EPZM), a clinical stage biopharmaceutical company creating innovative personalized therapeutics for patients with...


Apr 18, 2013, 08:30 ET Epizyme to Partner to Develop DOT1L Companion Diagnostic

Epizyme, Inc., a clinical stage biopharmaceutical company creating innovative personalized therapeutics for patients with genetically defined...


Mar 22, 2013, 08:30 ET Epizyme Granted First Patent Covering Personalized Therapeutic Drug Candidate E7438

Epizyme, Inc., a clinical stage biopharmaceutical company creating innovative personalized therapeutics for patients with genetically defined...


Feb 04, 2013, 08:30 ET Epizyme to Present at Upcoming Conferences in February

 Epizyme, Inc., a biopharmaceutical company leading the creation of personalized therapeutics to treat patients with genetically defined...


Oct 29, 2012, 08:30 ET Epizyme to Present at Upcoming Scientific and Financial Conferences in November

Epizyme, Inc., a company leading the creation of a new class of personalized therapeutics for patients with genetically defined cancers, today...